Q2 2013
Released Jul 9, 2013, during market hours
10-Q filed Jul 9, 2013, 9 days after period end · 0001477932-13-003117
Q2 2013 · 10-Q
Revenue—
Net Income-$1.37M-$1.37M N/M vs Q2 2012N/M vs Q1 2013
EPS Diluted-$0.31-$0.31 no prior Q2 2012 on fileN/M vs Q1 2013
Operating Income-$1,373,212—
Operating Cash Flowderived-$448—
Free Cash Flowderived-$448—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q2 2013 | Q2 2012 |
|---|---|---|
| Net Income | -$1.37M | -$61.23K |
| EPS Diluted | -$0.31 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lipocine Inc. · CIK 1535955 · Engraved from SEC EDGAR